News | October 21, 2008

Philips, King’s College London to Collaborate on New Imaging, Treatment of Heart Disease

October 22, 2008 - Royal Philips Electronics this week signed a new memorandum of understanding (MOU) for a five-year research collaboration with King’s College London to develop new medical imaging research projects with a particular focus on cardiology and cardiac electrophysiology.

Under the multi-million Euro agreement, Philips and King’s College London’s Division of Imaging Sciences focus on combining different imaging technologies, such as X-ray, MRI, ultrasound and CT, to help doctors navigate their way through a patient’s heart during minimal-invasive procedures.

Philips and King’s College London have already built a long-standing relationship, in particular through the college’s division of imaging sciences, in the areas of image analysis, especially in the field of magnetic resonance imaging, diagnostics and interventional guidance. The new agreement aims at the continuation of long-term collaboration in these fields and will also seek to establish new research projects into medical imaging for cardiovascular disease, cardiac arrhythmias and pediatric diseases.

“We have a long history of working closely with Philips and this new agreement will allow us to continue our research into cardiovascular disease for many more years,” said Reza Razavi, professor of pediatric cardiovascular science at King’s College London and head of the division of imaging sciences. “Through our research we hope to advance the way we diagnose and treat heart conditions and so improve the care of children and adults with cardiovascular disease.”

King's through its commercial arm, King’s College London Business, is focused on creating mutually beneficial industrial collaborations of this kind as part of its translational research agenda.

For more information: www.philips.com/newscenter, www.londonsahsc.org



Related Content

News | Cardiac Imaging

March 28, 2026 — When Ashley Perlow felt a sharp pain shoot across her chest and into both wrists, she didn't think it ...

Home April 01, 2026
Home
News | Cardiac Imaging

March 18, 2026 — Circle Cardiovascular Imaging (Circle CVI) has announced the expansion of its cvi42 cardiovascular ...

Home March 20, 2026
Home
News | Cardiac Imaging

March 19, 2026 — Heart disease is the leading cause of adult death worldwide, making cardiovascular disease diagnosis ...

Home March 20, 2026
Home
News | Cardiac Imaging

March 16, 2026 — The American Society for Preventive Cardiology (ASPC) will host its 2026 Virtual Imaging Symposium, a ...

Home March 17, 2026
Home
Feature | Cardiac Imaging

Sponsored Content — According to the American Heart Association, cardiovascular disease is the leading cause of death in ...

Home March 13, 2026
Home
News | Cardiac Imaging

March 6, 2026 — Building on its leadership in cardiac MR, Philips has received FDA 510(k) clearance for SmartHeart, an ...

Home March 09, 2026
Home
News | Cardiac Imaging

Feb. 26, 2026 — The U.S. Food and Drug Administration (FDA) has given 510(k) class II clearance of qXR-Detect, the ...

Home February 26, 2026
Home
News | Cardiac Imaging

Feb. 13, 2026 — Conavi Medical Corp. recently highlighted the publication of new peer-reviewed research titled “Deep ...

Home February 16, 2026
Home
News | Cardiac Imaging

Jan. 27. 2026 — Circle Cardiovascular Imaging Inc. has announced the release of cvi42 v6.4, the latest version of its ...

Home January 28, 2026
Home
News | Cardiac Imaging

Jan. 6, 2026 — UltraSight, a provider of AI-guided cardiac imaging workflows, has announced FDA clearance to expand its ...

Home January 16, 2026
Home
Subscribe Now